Product Profiles

Article

Femtosecond platform

Femtosecond platform

Ziemer Ophthalmic Systems has launched the Femto LDV Z Models Z2, Z4 and Z6. The new femtosecond platforms can be used for treating a wide range of applications in ocular surgery.

The systems operate at pulse frequencies in the megahertz range and use very low pulse energy. This enables excellent visual outcomes and faster recovery.

Upgrade for OCT system

Optovue has launched the realtime tracking upgrade for the RTVue Fourier-domain OCT system. RTVue can be used to scan and analyse both posterior and anterior segments. Retina, retina nerve fibre and cornea assessment can also be completed.

The system features real-time video image processing and can be used in conjunction with existing RTVue hardware. With RTVue eye movement of the patient can be followed during the OCT scanning process.

Illuminators for vitreoretinal surgery

The Goodlight LED illuminators, developed by Oertli, can be used for intraocular illumination during vitreoretinal surgery. The light enables the surgeon to adjust the required amount of illumination onto the phacoemulsification device.

Light intensity with the Goodlight LED is increased by 60% and the risk of photoretinitis is significantly reduced.

The Goodlight LED is available in sizes 20G, 23G and 25G and can be used in combination with other light sources.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.